BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 32781508)

  • 1. Sex-Specific Features of Calcific Aortic Valve Disease.
    Summerhill VI; Moschetta D; Orekhov AN; Poggio P; Myasoedova VA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32781508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β1 promotes fibrosis but attenuates calcification of valvular tissue applied as a three-dimensional calcific aortic valve disease model.
    Jenke A; Kistner J; Saradar S; Chekhoeva A; Yazdanyar M; Bergmann AK; Rötepohl MV; Lichtenberg A; Akhyari P
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1123-H1141. PubMed ID: 32986963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the use of biomarkers in calcific aortic valve disease.
    Beckmann E; Grau JB; Sainger R; Poggio P; Ferrari G
    J Heart Valve Dis; 2010 Jul; 19(4):441-52. PubMed ID: 20845891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 Is Downregulated in Human Stenotic Aortic Valves and Its Inhibition Promotes Dystrophic Calcification.
    Vieceli Dalla Sega F; Fortini F; Cimaglia P; Marracino L; Tonet E; Antonucci A; Moscarelli M; Campo G; Rizzo P; Ferrari R
    Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33255450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality and molecular imaging of matrix metalloproteinase activation in calcific aortic valve disease.
    Jung JJ; Razavian M; Challa AA; Nie L; Golestani R; Zhang J; Ye Y; Russell KS; Robinson SP; Heistad DD; Sadeghi MM
    J Nucl Med; 2015 Jun; 56(6):933-8. PubMed ID: 25908827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcification and extracellular matrix dysregulation in human postmortem and surgical aortic valves.
    Gomez-Stallons MV; Tretter JT; Hassel K; Gonzalez-Ramos O; Amofa D; Ollberding NJ; Mazur W; Choo JK; Smith JM; Kereiakes DJ; Yutzey KE
    Heart; 2019 Nov; 105(21):1616-1621. PubMed ID: 31171628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcific Aortic Valve Disease: Part 1--Molecular Pathogenetic Aspects, Hemodynamics, and Adaptive Feedbacks.
    Pasipoularides A
    J Cardiovasc Transl Res; 2016 Apr; 9(2):102-18. PubMed ID: 26891845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting vasoactive peptides for managing calcific aortic valve disease.
    Peltonen T; Ohukainen P; Ruskoaho H; Rysä J
    Ann Med; 2017 Feb; 49(1):63-74. PubMed ID: 27585243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteogenesis in calcified aortic valve disease: From histopathological observation towards molecular understanding.
    Liu X; Xu Z
    Prog Biophys Mol Biol; 2016 Nov; 122(2):156-161. PubMed ID: 26971958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro 3D model and miRNA drug delivery to target calcific aortic valve disease.
    van der Ven CF; Wu PJ; Tibbitt MW; van Mil A; Sluijter JP; Langer R; Aikawa E
    Clin Sci (Lond); 2017 Feb; 131(3):181-195. PubMed ID: 28057890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcific aortic stenosis.
    Lindman BR; Clavel MA; Mathieu P; Iung B; Lancellotti P; Otto CM; Pibarot P
    Nat Rev Dis Primers; 2016 Mar; 2():16006. PubMed ID: 27188578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simulation of early calcific aortic valve disease in a 3D platform: A role for myofibroblast differentiation.
    Hjortnaes J; Goettsch C; Hutcheson JD; Camci-Unal G; Lax L; Scherer K; Body S; Schoen FJ; Kluin J; Khademhosseini A; Aikawa E
    J Mol Cell Cardiol; 2016 May; 94():13-20. PubMed ID: 26996755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcific aortic valve disease: is it another face of atherosclerosis?
    Sathyamurthy I; Alex S
    Indian Heart J; 2015; 67(5):503-6. PubMed ID: 26432749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Label-free optical biomarkers detect early calcific aortic valve disease in a wild-type mouse model.
    Tandon I; Johns S; Woessner A; Perez J; Cross D; Ozkizilcik A; Muldoon TJ; Vallurupalli S; Padala M; Quinn KP; Balachandran K
    BMC Cardiovasc Disord; 2020 Dec; 20(1):521. PubMed ID: 33308143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osseous and chondromatous metaplasia in calcific aortic valve stenosis.
    Torre M; Hwang DH; Padera RF; Mitchell RN; VanderLaan PA
    Cardiovasc Pathol; 2016; 25(1):18-24. PubMed ID: 26386747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and calcific aortic valve stenosis: A systematic review.
    Guddeti RR; Patil S; Ahmed A; Sharma A; Aboeata A; Lavie CJ; Alla VM
    Prog Cardiovasc Dis; 2020; 63(4):496-502. PubMed ID: 32526213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone Morphogenetic Protein Signaling Is Required for Aortic Valve Calcification.
    Gomez-Stallons MV; Wirrig-Schwendeman EE; Hassel KR; Conway SJ; Yutzey KE
    Arterioscler Thromb Vasc Biol; 2016 Jul; 36(7):1398-405. PubMed ID: 27199449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoC-III is a novel inducer of calcification in human aortic valves.
    Schlotter F; de Freitas RCC; Rogers MA; Blaser MC; Wu PJ; Higashi H; Halu A; Iqbal F; Andraski AB; Rodia CN; Kuraoka S; Wen JR; Creager M; Pham T; Hutcheson JD; Body SC; Kohan AB; Sacks FM; Aikawa M; Singh SA; Aikawa E
    J Biol Chem; 2021; 296():100193. PubMed ID: 33334888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-Related Discordance Between Aortic Valve Calcification and Hemodynamic Severity of Aortic Stenosis: Is Valvular Fibrosis the Explanation?
    Simard L; Côté N; Dagenais F; Mathieu P; Couture C; Trahan S; Bossé Y; Mohammadi S; Pagé S; Joubert P; Clavel MA
    Circ Res; 2017 Feb; 120(4):681-691. PubMed ID: 27879282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global, Regional, and National Burden of Calcific Aortic Valve and Degenerative Mitral Valve Diseases, 1990-2017.
    Yadgir S; Johnson CO; Aboyans V; Adebayo OM; Adedoyin RA; Afarideh M; Alahdab F; Alashi A; Alipour V; Arabloo J; Azari S; Barthelemy CM; Benziger CP; Berman AE; Bijani A; Carrero JJ; Carvalho F; Daryani A; Durães AR; Esteghamati A; Farid TA; Farzadfar F; Fernandes E; Filip I; Gad MM; Hamidi S; Hay SI; Ilesanmi OS; Naghibi Irvani SS; Jürisson M; Kasaeian A; Kengne AP; Khan AR; Kisa A; Kisa S; Kolte D; Manafi N; Manafi A; Mensah GA; Mirrakhimov EM; Mohammad Y; Mokdad AH; Negoi RI; Thi Nguyen HL; Nguyen TH; Nixon MR; Otto CM; Patel S; Pilgrim T; Radfar A; Rawaf DL; Rawaf S; Rawasia WF; Rezapour A; Roever L; Saad AM; Saadatagah S; Senthilkumaran S; Sliwa K; Tesfay BE; Tran BX; Ullah I; Vaduganathan M; Vasankari TJ; Wolfe CDA; Yonemoto N; Roth GA;
    Circulation; 2020 May; 141(21):1670-1680. PubMed ID: 32223336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.